ALK and lung adenocarcinoma: Moreover, frequent decrease of FSTL1-BMP4-p-Smad1/5/8-Smad4 pathway observed in smokers and in ALK-fusion or KRAS mutant adenocarcinoma patients may facilitate the understanding of the molecular pathogenesis of lung adenocarcinoma.